8 |
Klinisk Biokemi i Norden · 3 2014
The XXXIVth Nordic Clinical Chemistry Congress
Göteborg, Sweden, September 16-19, 2014
Ola Hammarsten, Chairman of the Scientific Committee
One of the highlights of our Nordic
cooperation is the Nordic Clinical
Chemistry Congress. The Swedish
Society for Clinical Biochemistry
and Laboratory Medicine is hono-
red to host this congress in 2014.
The congress will take place on
September 16-19, 2014, in Göte-
borg, Sweden.
The Scientific Committee is now finalizing the pro-
gram with the overall theme “Future opportunities
in clinical chemistry,” that can be viewed in detail on
the official website, www. nfkk2014.se/.
The meeting will open with a west coast-inspired
lunch, a seminar discussing the medical implications
of how we eat, why antioxidants might harm you and
how the gut flora affects your health, followed by a
generous Welcome Reception hosted by the City of
Göteborg and the Region of Västra Götaland.
The themes for the second day are cardiology and
technology. The first speaker of the day will be Profes-
sor Bertil Lindahl fromUppsala who summarizes the
latest in biomarkers for the diagnosis of myocardial
infarction. This is followed by a seminar on novel bio-
markers able to predict the likelihood of developing
cardiac disease. In the afternoon we will learn about
new diagnostic cardiac biomarkers. Professor Martin
Möckel from Berlin will describe a novel application
of copeptin/ADH and its use in the emergency ward.
Professor Per Venge, Uppsala, will tell us about novel
applications of cardiac troponin.
The technology theme involves morning seminars
on challenges in point-of-care testing and novel
laboratory techniques in company pipelines. In the
afternoon, professor Fredrik Höök from Chalmers
University of Technology will present his perspective
of the technological forefront. The technology theme
will close with a seminar on how Next Generation
Sequencing will change our ability to diagnose and
predict disease. This seminar will also cover the qua-
